143 related articles for article (PubMed ID: 16922908)
1. Hypoxia and angiogenesis in pancreatic cancer.
Garcea G; Doucas H; Steward WP; Dennison AR; Berry DP
ANZ J Surg; 2006 Sep; 76(9):830-42. PubMed ID: 16922908
[TBL] [Abstract][Full Text] [Related]
2. Angiogenesis of gastrointestinal tumours and their metastases--a target for intervention?
Garcea G; Lloyd TD; Gescher A; Dennison AR; Steward WP; Berry DP
Eur J Cancer; 2004 Jun; 40(9):1302-13. PubMed ID: 15177488
[TBL] [Abstract][Full Text] [Related]
3. Anti-angiogenic therapy against gastrointestinal tract cancers.
Iwasaki J; Nihira S
Jpn J Clin Oncol; 2009 Sep; 39(9):543-51. PubMed ID: 19531544
[TBL] [Abstract][Full Text] [Related]
4. Anti-angiogenesis therapy in pancreatic carcinoma.
Saif MW
JOP; 2006 Mar; 7(2):163-73. PubMed ID: 16525200
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional anti-angiogenesis therapy of human pancreatic cancer.
Xie K; Wei D; Huang S
Cytokine Growth Factor Rev; 2006 Jun; 17(3):147-56. PubMed ID: 16516532
[TBL] [Abstract][Full Text] [Related]
6. [The importance of angiogenesis in pancreatic cancer].
Myśliwiec P; Dadan J
Przegl Lek; 2009; 66(3):155-8. PubMed ID: 19689042
[TBL] [Abstract][Full Text] [Related]
7. Effect of Src kinase inhibition on metastasis and tumor angiogenesis in human pancreatic cancer.
Ischenko I; Guba M; Yezhelyev M; Papyan A; Schmid G; Green T; Fennell M; Jauch KW; Bruns CJ
Angiogenesis; 2007; 10(3):167-82. PubMed ID: 17486419
[TBL] [Abstract][Full Text] [Related]
8. Targeting angiogenesis in head and neck cancer.
Seiwert TY; Cohen EE
Semin Oncol; 2008 Jun; 35(3):274-85. PubMed ID: 18544442
[TBL] [Abstract][Full Text] [Related]
9. Novel therapies for pancreatic cancer.
Wolff RA
Cancer J; 2001; 7(4):349-58. PubMed ID: 11561610
[TBL] [Abstract][Full Text] [Related]
10. The oral multitarget tumour growth inhibitor, ZK 304709, inhibits growth of pancreatic neuroendocrine tumours in an orthotopic mouse model.
Scholz A; Wagner K; Welzel M; Remlinger F; Wiedenmann B; Siemeister G; Rosewicz S; Detjen KM
Gut; 2009 Feb; 58(2):261-70. PubMed ID: 18829975
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of insulin-like growth factor-I receptor (IGF-IR) using NVP-AEW541, a small molecule kinase inhibitor, reduces orthotopic pancreatic cancer growth and angiogenesis.
Moser C; Schachtschneider P; Lang SA; Gaumann A; Mori A; Zimmermann J; Schlitt HJ; Geissler EK; Stoeltzing O
Eur J Cancer; 2008 Jul; 44(11):1577-86. PubMed ID: 18445520
[TBL] [Abstract][Full Text] [Related]
12. The novel hypoxic cell radiosensitizer, TX-1877 has antitumor activity through suppression of angiogenesis and inhibits liver metastasis on xenograft model of pancreatic cancer.
Miyake K; Shimada M; Nishioka M; Sugimoto K; Batmunkh E; Uto Y; Nagasawa H; Hori H
Cancer Lett; 2008 Dec; 272(2):325-35. PubMed ID: 18762366
[TBL] [Abstract][Full Text] [Related]
13. Interferon-mediated anti-angiogenic therapy for neuroblastoma.
Streck CJ; Ng CY; Zhang Y; Zhou J; Nathwani AC; Davidoff AM
Cancer Lett; 2005 Oct; 228(1-2):163-70. PubMed ID: 15927362
[TBL] [Abstract][Full Text] [Related]
14. Clinical implications of tumor-associated neovascularization and current antiangiogenic strategies for the treatment of malignancies of pancreas.
Pluda JM; Parkinson DR
Cancer; 1996 Aug; 78(3 Suppl):680-7. PubMed ID: 8681307
[TBL] [Abstract][Full Text] [Related]
15. [Angiogenesis and hematological malignancies].
Iversen PO
Tidsskr Nor Laegeforen; 2003 Nov; 123(22):3198-200. PubMed ID: 14714007
[TBL] [Abstract][Full Text] [Related]
16. [The actual place of anti-angiogenesis in non-small cell lung cancer].
Mennecier B
Rev Mal Respir; 2007 Oct; 24(8 Pt 2):6S198-205. PubMed ID: 18235414
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia stimulates pancreatic stellate cells to induce fibrosis and angiogenesis in pancreatic cancer.
Masamune A; Kikuta K; Watanabe T; Satoh K; Hirota M; Shimosegawa T
Am J Physiol Gastrointest Liver Physiol; 2008 Oct; 295(4):G709-17. PubMed ID: 18669622
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic inhibition of Sp1 expression in growing tumors by mithramycin a correlates directly with potent antiangiogenic effects on human pancreatic cancer.
Yuan P; Wang L; Wei D; Zhang J; Jia Z; Li Q; Le X; Wang H; Yao J; Xie K
Cancer; 2007 Dec; 110(12):2682-90. PubMed ID: 17973266
[TBL] [Abstract][Full Text] [Related]
19. Angiogenesis in pancreatic cancer: current research status and clinical implications.
Li S; Xu HX; Wu CT; Wang WQ; Jin W; Gao HL; Li H; Zhang SR; Xu JZ; Qi ZH; Ni QX; Yu XJ; Liu L
Angiogenesis; 2019 Feb; 22(1):15-36. PubMed ID: 30168025
[TBL] [Abstract][Full Text] [Related]
20. Interferon-alpha in combination with chemotherapy has potent antiangiogenic properties in an orthotopic mouse model for pancreatic adenocarcinoma.
Zhu Y; Tibensky I; Schmidt J; Hackert T; Ryschich E; Jäger D; Büchler MW; Märten A
J Immunother; 2008 Jan; 31(1):28-33. PubMed ID: 18157009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
